title: Do antihypertensives make tranylcypromine safer? Three case reports.
authors.forename: Bonnie P
authors.initials: BP
authors.lastname: Taylor
authors.forename: Frederic M
authors.initials: FM
authors.lastname: Quitkin
authors.forename: Patrick J
authors.initials: PJ
authors.lastname: McGrath
authors.forename: Jonathan W
authors.initials: JW
authors.lastname: Stewart
mesh_terms: D017311:Amlodipine / Q000008:administration & dosage / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy; D004359:Drug Therapy, Combination; D004656:Enalapril / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000139:chemically induced* / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D014191:Tranylcypromine / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D008996:Monoamine Oxidase Inhibitors; D017311:Amlodipine; D014191:Tranylcypromine; D004656:Enalapril